In Consolidated Inter Partes Reviews, Board Confirms Patentability

Mealey's (July 12, 2018, 12:07 PM EDT) -- ALEXANDRIA, Va. — A challenge to a patented method for treating relapsing-remitting multiple sclerosis (RR-MS) was turned away by the Patent Trial and Appeal Board on July 11, in a win for patent owner Novartis A.G. (Apotex Inc., et al. v. Novartis A.G., Nos. IPR2017-00854, IPR2017-01550, IPR2017-01946 and IPR2017-01929, PTAB)....